Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT00324155
Brief Title: Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma

First Submitted : May 8, 2006
First Submitted that Met QC Criteria : May 9, 2006
First Posted : May 10, 2006 (Estimate)

Results First Submitted : January 22, 2014
Results First Submitted that Met QC Criteria : January 22, 2014
Results First Posted : March 10, 2014 (Estimate)

Certification/Extension First Submitted : January 29, 2011
Certification/Extension First Submitted that Met QC Criteria : June 17, 2011
Certification/Extension First Posted : June 20, 2011 (Estimate)

Last Update Submitted that Met QC Criteria : October 24, 2014
Last Update Posted : November 2, 2014 (Estimate)